This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of CYCLOSPORINE 0.05% EYE EMULS 30S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order valued at $10,354.96 with a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated under any set-aside program.
The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/18/25, 9:44 AM